14 September 2022 - NICE has published evidence-based recommendations on the use of dexamethasone intravitreal implant for the treatment of adults with visual impairment caused by diabetic macular oedema.

Dexamethasone intravitreal implant is recommended as an option for the treatment of adults with visual impairment caused by diabetic macular oedema only if their condition has not responded well enough to, or if they cannot have non-corticosteroid therapy.

Read NICE technology appraisal guidance